{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T19:28:47Z","timestamp":1784834927035,"version":"3.55.0"},"reference-count":38,"publisher":"BMJ","issue":"6","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Med Ethics"],"accepted":{"date-parts":[[2022,8,11]]},"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:p>The COVID-19 pandemic has exacerbated the drug poisoning epidemic in a number of ways: individuals use alone more often, there is decreased access to harm reduction services and there has been an increase in the toxicity of the unregulated drug supply. In response to the crisis, clinicians, policy makers and people who use drugs have been seeking ways to prevent the worst harms of unregulated opioid use. One prominent idea is safe supply. One form of safe supply enlists clinicians to prescribe opioids so that people have access to drugs of known composition and strength. In this paper, we assess the ethical case for clinicians providing this service. As we describe, there is much that is unknown about safe supply. However, given the seriousness of the overdose death epidemic and the current limited evidence for safe supply\u2019s efficacy, we argue that it is ethically permissible for clinicians to begin prescribing opioids for some select patients.<\/jats:p>","DOI":"10.1136\/jme-2021-108087","type":"journal-article","created":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T17:27:47Z","timestamp":1660930067000},"page":"377-382","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":11,"title":["Prescribing safe supply: ethical considerations for clinicians"],"prefix":"10.1136","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6011-905X","authenticated-orcid":false,"given":"Katherine","family":"Duthie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Mathison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helgi","family":"Eyford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S Monty","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,8,19]]},"reference":[{"issue":"5","key":"2024052219355447000_49.6.377.1","doi-asserted-by":"crossref","first-page":"556","DOI":"10.15288\/jsad.2020.81.556","article-title":"Addressing the Syndemic of HIV, hepatitis C, overdose, and COVID-19 among people who use drugs: the potential roles for decriminalization and safe supply","volume":"81","author":"Bonn","year":"2020","journal-title":"J Stud Alcohol Drugs"},{"issue":"1","key":"2024052219355447000_49.6.377.2","doi-asserted-by":"crossref","DOI":"10.1186\/s12954-020-00370-7","article-title":"Challenges in maintaining treatment services for people who use drugs during the COVID-19 pandemic","volume":"17","author":"Dunlop","year":"2020","journal-title":"Harm Reduct J"},{"key":"2024052219355447000_49.6.377.3","unstructured":"Canadian Centre on Substance Use and Addiction [Internet]. . Changes related to COVID-19 in the illegal drug supply and access to services, and resulting health harms (CCENDU alert. Ottawa ON: CCSA, 20212020. ccsa.ca\/changes-related-covid-19-illegal-drug-supply-and-access-services-and-resulting-harms. (cited 2021 Dec 16)."},{"issue":"1","key":"2024052219355447000_49.6.377.4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10826080701690680","article-title":"The ethics of harm reduction","volume":"43","author":"Kleinig","year":"2008","journal-title":"Subst Use Misuse"},{"issue":"1-2","key":"2024052219355447000_49.6.377.5","first-page":"26","article-title":"The effect of methadone maintenance therapy on harm reduction in opiate dependents in kerman socio-behavioral consulting centers","volume":"2","author":"Parvaresh","year":"2010","journal-title":"Addict Health"},{"key":"2024052219355447000_49.6.377.6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0810635"},{"issue":"1","key":"2024052219355447000_49.6.377.7","doi-asserted-by":"crossref","DOI":"10.1186\/s12954-017-0177-7","article-title":"Harm reduction in name, but not substance: a comparative analysis of current Canadian provincial and territorial policy frameworks","volume":"14","author":"Hyshka","year":"2017","journal-title":"Harm Reduct J"},{"issue":"2","key":"2024052219355447000_49.6.377.8","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/jclp.20669","article-title":"Harm reduction therapy: a practice-friendly review of research","volume":"66","author":"Logan","year":"2010","journal-title":"J Clin Psychol"},{"key":"2024052219355447000_49.6.377.9","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.171060"},{"key":"2024052219355447000_49.6.377.10","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.201618"},{"issue":"12","key":"2024052219355447000_49.6.377.11","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1111\/add.14747","article-title":"Supervised consumption sites: a nuanced assessment of the causal evidence","volume":"114","author":"Caulkins","year":"2019","journal-title":"Addiction"},{"key":"2024052219355447000_49.6.377.12","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.74065"},{"key":"2024052219355447000_49.6.377.13","doi-asserted-by":"crossref","unstructured":"Bache I . Evidence, policy, and well-being. Switzerland: Palgrave Pivot, 2019: 11.","DOI":"10.1007\/978-3-030-21376-3_2"},{"issue":"12","key":"2024052219355447000_49.6.377.14","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1111\/bcp.14082","article-title":"Risk assessment of using off-label morphine sulfate in a population-based retrospective cohort of opioid-dependent patients","volume":"86","author":"Bertin","year":"2020","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"2024052219355447000_49.6.377.15","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1001\/jamapsychiatry.2016.0109","article-title":"Hydromorphone compared with diacetylmorphine for long-term opioid dependence: a randomized clinical trial","volume":"73","author":"Oviedo-Joekes","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"2024052219355447000_49.6.377.16","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2020.102769","article-title":"Tackling the overdose crisis: the role of safe supply","volume":"80","author":"Ivsins","year":"2020","journal-title":"Int J Drug Policy"},{"issue":"1","key":"2024052219355447000_49.6.377.17","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1001\/virtualmentor.2013.15.1.oped1-1301","article-title":"A call to integrate ethics and evidence-based medicine","volume":"15","author":"Upshur","year":"2013","journal-title":"AMA J. Ethics"},{"key":"2024052219355447000_49.6.377.18","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.shpsa.2020.08.005","article-title":"Countering medical nihilism by reconnecting facts and values","volume":"84","author":"Upshur","year":"2020","journal-title":"Stud Hist Philos Sci"},{"key":"2024052219355447000_49.6.377.19","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39490.551019.BE"},{"key":"2024052219355447000_49.6.377.20","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39070.527986.68"},{"key":"2024052219355447000_49.6.377.21","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2020.102840","article-title":"Ranking evidence in substance use and addiction","volume":"83","author":"Reddon","year":"2020","journal-title":"Int J Drug Policy"},{"key":"2024052219355447000_49.6.377.22","unstructured":"Beauchamp TL , Childress CF . Principles of biomedical ethics. 8th ed. Oxford, UK: Oxford University Press, 2019."},{"key":"2024052219355447000_49.6.377.23","unstructured":"Healthy Debate . Urgent call on clinicians: prescribe alternatives to poisoned drug supply. Toronto: Health Debate, 2019. healthydebate.ca\/2019\/06\/topic\/safer-supply-opioids\/"},{"issue":"1","key":"2024052219355447000_49.6.377.24","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11524-020-00489-9","article-title":"\"It's Helped Me a Lot, Just Like to Stay Alive\": a Qualitative Analysis of Outcomes of a Novel Hydromorphone Tablet Distribution Program in Vancouver, Canada","volume":"98","author":"Ivsins","year":"2021","journal-title":"J Urban Health"},{"key":"2024052219355447000_49.6.377.25","unstructured":"Canadian Association of People who Use Drugs . Safe supply concept document. Canada: CAPUD, 2019. capud.ca\/capud-resources\/safe-supply-projects. (cited 2021 Dec 16)."},{"key":"2024052219355447000_49.6.377.26","doi-asserted-by":"publisher","DOI":"10.1007\/s11019-006-9000-z"},{"key":"2024052219355447000_49.6.377.27","doi-asserted-by":"crossref","unstructured":"Flanigan J . Pharmaceutical freedom: why patients have a right to Self-Medicate. New York: Oxford University Press, 2017.","DOI":"10.1093\/oso\/9780190684549.001.0001"},{"key":"2024052219355447000_49.6.377.28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-8519.2006.00470.x"},{"key":"2024052219355447000_49.6.377.29","doi-asserted-by":"publisher","DOI":"10.1353\/cjp.2006.0018"},{"key":"2024052219355447000_49.6.377.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2007.09.007"},{"issue":"4","key":"2024052219355447000_49.6.377.31","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1177\/1073110517750600","article-title":"The epidemic as stigma: the bioethics of opioids","volume":"45","author":"Buchman","year":"2017","journal-title":"J Law Med Ethics"},{"key":"2024052219355447000_49.6.377.32","unstructured":"Mate G . In the realm of hungry ghosts: close encounters with addiction. Toronto: Knopf Canada, 2009."},{"key":"2024052219355447000_49.6.377.33","unstructured":"National Academies of Sciences, Engineering and Medicine; Health and Medicine Division; Board on Health Sciences Policy; Committee on Pain Management and Regulatory Strategies to Address Prescription Opioid Abuse . Evidence on Strategies for Addressing the Opioid Epidemic. In: Philips JK , Ford MA , Bonnie RJ , eds. Pain management and the opioid epidemic: balancing societal and individual benefits and risks of prescription opioid use. Washington (DC: National Academies Press (US), 2017: 267\u2013358."},{"key":"2024052219355447000_49.6.377.34","unstructured":"Stewart B . Government-sanctioned safe supply not enough to get some off fentanyl-laced street drugs. CBC News [internet], 2021. Available: www.cbc.ca\/news\/canada\/british-columbia\/drugs-covid-supply-1.5668370 [Accessed 06 Dec 2021]."},{"issue":"5","key":"2024052219355447000_49.6.377.35","doi-asserted-by":"crossref","first-page":"164","DOI":"10.18773\/austprescr.2015.058","article-title":"Drug diversion","volume":"38","author":"Wood","year":"2015","journal-title":"Aust Prescr"},{"issue":"9","key":"2024052219355447000_49.6.377.36","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1001\/jamainternmed.2019.1064","article-title":"Association of opioid overdose with opioid prescriptions to family members","volume":"179","author":"Khan","year":"2019","journal-title":"JAMA Intern Med"},{"key":"2024052219355447000_49.6.377.37","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2010.03014.x"},{"key":"2024052219355447000_49.6.377.38","unstructured":"Howorun C . \u2018Unexplained losses\u2019 of opioids on the rise in Canadian hospitals; morphine, hydromorphone, oxycodone, codeine, and fentanyl all seem to disappear without a known cause from Canadian hospitals. Macleans, 2017. Available: www.macleans.ca\/society\/health\/unexplained-losses-of-opioids-on-the-rise-in-canadian-hospitals\/ [Accessed 16 Dec 2021]."}],"container-title":["Journal of Medical Ethics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jme-2021-108087","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T02:36:20Z","timestamp":1716431780000},"score":1,"resource":{"primary":{"URL":"https:\/\/jme.bmj.com\/lookup\/doi\/10.1136\/jme-2021-108087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,19]]},"references-count":38,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,5,22]]},"published-print":{"date-parts":[[2023,6]]}},"alternative-id":["10.1136\/jme-2021-108087"],"URL":"https:\/\/doi.org\/10.1136\/jme-2021-108087","relation":{},"ISSN":["0306-6800","1473-4257"],"issn-type":[{"value":"0306-6800","type":"print"},{"value":"1473-4257","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,19]]}}}